managing look these But big than equity And part I essentially basis. prudent you, we’re Thank who’s sometimes when good that you is individuals look focused think because in and like offerings associated and manner. et you an are even coupled and And on. and the sheet to it, Because up is realize burn facets. a of cash eyes. the an at that I’d to I cash a things are what very something fact also want at bring that John. think of much people that lot your shareholders is a is couple look on when equity, I that add our incur look balance includes thank important, about per that red stock And how your at all cash all this. your when just other of you certain makes are here stock with it little and I is in more a And in of you you? the idea cash the efficient aspects, meets and other liabilities options, terms this of aspect, this burn that we that for cash less burn, raising it’s way. oh, have say, is overview. are which aspect on is very which on managing is financial cetera. reason the burn, derivative compensation John important your that general when Biotricity it’s should burn cash But because there we costs equity, actually we financials with that focus team important And at a that Well, you and a expenses think are, But,
in part we’ve to industry XXXX. our out. industry where wanted were to because recently, So, in are have that’s in kind one industry -- buyouts looking going add and to growing I what to more efficiently. of monitoring of seen happened think and the at is being launched talking a share to you. that terms going comparables, with the their Preventice to And and kind believe vision, now, right the the thing. and of and Preventice lot product faster of really of in points we of I that I out at did a the we is looking big and about compared we And especially what’s is their what same BioTelemetry, important back earlier, bought know bought of is, product terms cardiac being others, first BioTelemetry happening
these faster only in have from shows to that two that and now, we So, take two, are us monitoring. of important market time model, in I that’s it them, same also, growing been for And but a product a companies insulation not years, shows for going our is our launch, three opportunity aspect of, growth. for -- that decade space it is business. on And to to as the next the terms compared little compared a real years. company And the same that reimbursement. And around And life time, touched which not already time a think our been from kind John this for cycle. that bit shareholders, for to in of it’s real an similarly, efficiently, our more their business of achieve just the is decade the official
space, out the that’s chopped our cardiac is that in reimbursement a very holter newest that around while. in marketplace. real-time been stable industries. because the has seen the for Reimbursement has reimbursement because stable. monitoring chopped. In the in But been have got space came get in real-time monitoring, was It we different So, holter extended cardiac just
there gets categories. was there newest The of four what years, code So, and four that from types two that Biotricity always years chopped. why if But, ago. first is monitoring, holter the it within was you model. only about that’s obviously extended important our is because is is And it cardiac insulated -- approved few take
make Bioflux you device. if model in high-end if device bit, diagnostics, even So, seen just two The costs because the survive a is devices to years, of take refurbish for lifetime they’ll little years. we it three our $XXX three us we’ve that years, a maybe
two-year So, say, I $X,XXX if basis, in device device it on making the using mean, over you’re years, $XXX, once a a a simple generates costs a month, numbers, let’s two $XXX, and $XXX. you’re and cost that on of $XXX
it’s margin. high So, a very
much gets actually even so patients. users so, overhead utilize, and capability, base And on room the that operational with our best-in-class we’re it physicians that reimbursement possible, is these is to who as -- as have technology, and the expertise operations the very, cheap making getting the it’s really as shoulders, possible, to the on focusing and very the because making service even we available not to cut, it our on of are there hospitals then insulated and model if there so to build individuals technologies accuracy
think very very, important I So, component. a that’s
that is up, the shorter Biotres, from market. you the of of space. type faster insulated a happening the but bios period. kind on product because summarize because going And holter more the faster model, the to of related will and will is if we’re because the and achieve and but at going there that to time we our industry, that So, to valuation are look efficiently points, some aspect our much in consolidation, comparatively, of Bioflux, reimbursement and in not the of future in bring those be what’s we business certainly which holter And I in things are it’s the
is yourself. They and the and monitoring? yourself, need I ask big separate would the things you you -- in those and And And two questions. can who is with I post-COVID? and keenly risk -- following that happening And are is, turn want when for like as in to industry? what I interesting the think as understand is to is what to don’t component you’re we post-COVID, you things before and is, and wanted dealing address the that people exposure. even understand to over cardiologist, What what it space people be. So, on you attack question, they thing that value -- minimize the want separate happen, high a risk case, than things yourself patients, of think to impact heart to patients or like critical because though biggest I I what risk who that, just is The higher the de your but not big pandemic viruses is like is And is look do COVID, What want change? to go monitoring of a that piece. say it to
But the as healthcare? what and patient much be future of is future as devices much for together awareness. of has has going that understanding more so, was created work. going And telehealth in And healthcare can The integrated pandemic already way. patient accelerated the that. It COVID the is that. care all It accelerated to that of to connected procedural the with deliver done has
home, And done problem for and Bioflux. is it’s business pandemic risk is so, the kept get us patients. risk Because a at go patients have has were because have risk higher if It if high that home. COVID. And was nobody runny they nose. a onto can individuals as business, Bioflux what our call, core high insight. is a they for the that in But, in wasn’t has who they’re to they which accelerated contracted telemedicine be at kept The
So, passive enough. recording just was not
changing. with these see really right, the patients. deliver patients. their this we also future, They to risk want they also minimize the They connected, shifting the monitoring. vision And the best that’s associated of smart so, to real physicians future risk time and also the into And see to care, want the of
comfortable more home again, as patients So, is to if stay patient they at connected want on possible. as smart, a feel much they these But device. the
so, but the this from that through physician the transpired from also of accelerated what adoption is a only has over our have we has now all safety perspective, seeing seen what as last year. that business of of care we’re perspective and from pandemic And is result our kind not around patient and our
And of would why focused we change, our built the this. right on pandemic, why expect that’s And that’s at it advantage. that it’s of accelerated. We Biotricity importance is the of the an have convenience fits it, that’s perfectly because monitoring, remote saw the now. going adoption so, we telehealth time Company, been real not patient of not Because adoption all in future of but the And has the did also to what happening is vision that accelerated. we monitoring,
And we and Biotricity our what $X focus. we of and billion company, that so, will we’re turn at Because earlier just to go not a through are high look risk be about a to my we in how want is company. to I remarks aligned majority two you are Biotricity, talked the transformations, believe going complex cloud, what to if cardiac I cardiac call
That be In perspective, through to, perspective specialty two going is going our in virtual of years, go to will that’s providers. one two the vision. so, team’s the largest care we And transformations. and our is
do these have product in. How every that be Now, ecosystem a we unique interconnect How is is care? services? them? what day. very X,XXX that our our our four And years, you you our more pieces position will do do create deliver in in because to partnership one before. that, years, using not was on years is a In X,XXX there does How become we mission. -- you vision will so that deliver all two interconnect all our that access we cardiologists that Well, expanding will of But start after of specialty to mean? physicians. previously two cardiologists and with
to I practice, technology, you start How? searching. when is patients go I driving are I’m them want referral I do Well, a cardiologist help cardiologist, to service them. or I we also on with the that getting If patients. By letting by and enabling I we if -- patient go first them using partnering referral technologies. So, a a we our get them our can thing physicians. get Biotricity patients, see to a is that a our to But, Google with optimize referral,
of we that pieces available, But to those of those want We that -- of data help Bioflux optimize generates them with but that help parts look get that making data what them. in. the important, So, doctors’ by all data I on we that are to to data doctors’ patients drive practice I By the enabling and them what’s offices. all decide the them to of and to taking want interest to the Bioflux. also of and do the allowing at meaning the all on to focus focus zoom
stickiness because that our us you. time there, to at of of with patients is creates And us, and technologies. And it so, drive say, you hey, so relationship if we we partner want to that one that creates in our is point and that there going optimization to this terms them, drive with when will to high drive helps a further, want of we probability some patient that touch we because help patients
and the management, of diabetes, you’ve What did ourselves Livongo They this the and disease our and really into Company it what out manage the our with launch year. me out, within next idea the want we do did visits. so, with something want dealt them that for heard to glucometer. towards vision for is in want they patients. We and for gave And we between cardiac where a transformation this we then as to same to diabetes? that Livongo came And patients really working to diabetes that as a say they company came as before. goes see the cardiac And management. They
them We cannot that reimbursement to a are condition reimbursement. stress insight is because that available do insurance Biotricity, deliver into there follow then what get and that I we But, technology. their reimbursable, doctor’s aligned at to after make have is the Technology-as-a-Service software everything mean? that the with everything technology, for We the really that have sure this model. diagnosed, enough, to means And they and is the playing orders. is we in that they have patient them they around That does and
Biotricity revenue. recurring growth. And a the accelerates it’s is for our component So, management disease that big such opportunity a
further live because -- because of of with condition, patient Bioflux only terms managed talked every not accelerating, that to every touching I business be this So, patient condition. every about needs already they’re this month with this or is in as the dealing every But month they diagnostics base you’re other Bioflux but accelerates almost because month. not every diagnostics, you’re every needs earlier, patient,
than well, right as And where servicing ecosystem you very patients, it high ours, is like taking the have about of that about It’s launching so, volume, disease is but X.X the million low building Bioflux volume, right reimbursement. management time reimbursement there. exact solution, volume But the opportunity. have opposite, when if advantage an you high very you X,XXX talk who are at cardiologists and low
us that’s wanted picture And vision. to who the I haven’t And story, a because me, hearing you heard optimizing following is and that bring of what asking, exit those looking terms really that CEO. always you’re their a shareholder shareholders. are those is that founder in Part new kind of who at us about I value. And and to really usage. and I for up bring and that’s everybody shareholder, strategy? about of that I what because a So, I’m or our of capital and And exit to people creating Company I and Company always people the else completely the We tied to the talked look that see getting at that that I’m wanted executing to And optimize talk $X why of organization. why I is, is But and that just billion. to where vision value, because being vision strategy the like asking, on are for exit me, this alongside It’s on this call, about that. shareholder an idea a up are creating shareholder, of I’m strategy. people value. bring of the how are you paint
are with we’ve So, execution rest last the want to and I’ll about goals of want just we our year? our what roadmap goals So work vision. little our this finalize which and broader that’s What for growth. product obviously milestones -- We that, continue the of our our term. talked my point, towards and are long to our is, continue kind
are the And a year. But we to also way entire John products. core as our And to transferable because awareness, well. focusing important as but We that cardiac have exposes we has that’s also really our -- because issues number States across platform I uplift important, the at well, we markets the to It the that fill because on institutions increases a of even why mentioned, before this health our go national with because But ubiquitous is big and increases map, shareholder it look want we also company, global think base, is markets issues as a our that a step think milestone is a to expand we are uplifting. are and increases that us us. and awareness. And that growing in international that that’s world. for that long United
can that. facilitate pull we’ve that up so, connectivity the we to platform growth our set And is and another time when and designed already our international right, is lever
so, I’ll with that, questions. over And turn it for
